STOCKHOLDERS' EQUITY (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Components of the stock-based compensation programs recorded as expense |
The following table summarizes the components of the Company’s stock-based compensation programs recorded as expense:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summarized information on unvested restricted stock units outstanding |
The following table summarizes information on unvested restricted stock outstanding as of March 31, 2017:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||